Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
about
Biomarkers for sporadic Creutzfeldt-Jakob diseaseNanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers.In vivo detection of cucurbit[6]uril, a hyperpolarized xenon contrast agent for a xenon magnetic resonance imaging biosensorPenetrating the Blood-Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles.Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's diseaseEpistasis analysis links immune cascades and cerebral amyloidosis.Increasing the Receptor Tyrosine Kinase EphB2 Prevents Amyloid-β-induced Depletion of Cell Surface Glutamate Receptors by a Mechanism That Requires the PDZ-binding Motif of EphB2 and Neuronal Activity.A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.Transition from identity to bioactivity-guided proteomics for biomarker discovery with focus on the PF2D platform.Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's diseaseNanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.Nano-biosensors to detect beta-amyloid for Alzheimer's disease management.Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation.Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.Probing amylin fibrillation at an early stage via a tetracysteine-recognising fluorophore.A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-β oligomers.A Metal-Free Method for Producing MRI Contrast at Amyloid-β.Identification of type IV collagen exposure as a molecular imaging target for early detection of thoracic aortic dissection.Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.Droplet-based magnetic bead immunoassay using microchannel-connected multiwell plates (μCHAMPs) for the detection of amyloid beta oligomers.Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.Fluoro-substituted cyanine for reliable in vivo labelling of amyloid-β oligomers and neuroprotection against amyloid-β induced toxicity.Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.Towards clinically translatable in vivo nanodiagnostics.Phyto-Therapeutic and Nanomedicinal Approaches to Cure Alzheimer's Disease: Present Status and Future Opportunities
P2860
Q26739995-EB3BEB40-66CC-40CA-8C82-A532EC468705Q28546877-7BD9A576-8DFC-4EDE-9472-8BF95E5870ADQ28818723-DEA8BA1A-1A4B-4E49-907B-6428ACB5671EQ30365829-EAF132BF-96BD-4C01-9531-7022FF6498C7Q35327172-9EAA8B62-507F-4B15-A7F2-CFADDB07C704Q35643397-15ECD9EA-AD21-4B2B-A681-3B0CDBBE14AEQ36337137-36DCFA55-EAF9-4847-8E7D-99C53F7A1C84Q36489274-FED5106D-CC67-4A8A-A365-4F330381A157Q37061713-3EFA661D-CD00-4DEE-AC52-6A5108878EEEQ37724402-9E2609A7-9C17-4C73-AF4E-2C515CD7DBB0Q38552059-5BA697B2-5187-490E-99A8-9DDEC4CC4B93Q38590807-3D7EA144-453A-42C7-A521-CF80541E5187Q38686370-86550240-F836-445E-9C82-3FCD6F0A0123Q38724884-0F705DD3-7B40-4633-AC09-DEDAC00D84F5Q38833788-9CFEBEE7-11EB-41BF-9520-68332482A82DQ38938961-75AFDE90-C31C-4A98-BADF-91A5781500EDQ41657894-9A36B4AB-3E6C-4B70-8BF4-20BE1A9D89CCQ46341580-59F9BE02-FC91-4432-8178-BCF6CE85151DQ46451313-761DC643-DC36-4EF2-97D6-87B1D003F5A2Q47123907-F965F00A-1A22-495C-983C-5E6C9D57CEA5Q47351358-F8DBD063-F48D-4A5A-AE4C-3959685F0DDFQ47861975-55CAEFC4-9E5B-446C-BB44-8E85DE2D2497Q48732784-AFDCE697-1481-4FFF-B42D-B8162E9F4EA4Q50199042-43F63087-DE4F-4F87-9AB3-1C83B75DED0BQ52606045-48FEFB0B-F0F8-4689-8C1E-056A51E63676Q54722624-AC20EA9C-9609-480A-A7A4-8A2199589439Q54977832-9883FECD-01CF-4C57-BC25-E89BC2E459B0Q54985361-38C821D2-3099-4D1A-82A5-E8652F32AB76Q58571824-EB2E9320-0EFB-402F-85C4-F742BCCA280E
P2860
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@ast
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@en
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@nl
type
label
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@ast
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@en
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@nl
prefLabel
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@ast
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@en
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease.
@nl
P2093
P2860
P356
P1476
Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease
@en
P2093
Hrushikesh Joshi
James Sbarboro
Joseph Phan
Keith MacRenaris
Kirsten L Viola
Maíra A Bicca
Mrinmoy De
Pascale Lacor
P2860
P2888
P356
10.1038/NNANO.2014.254
P407
P577
2014-12-22T00:00:00Z
P5875
P6179
1040107801